Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
3.200
-0.080 (-2.44%)
Jan 14, 2025, 4:00 PM EST - Market closed
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $477.06 million as of January 14, 2025. Its market cap has increased by 46.35% in one year.
Market Cap
477.06M
Enterprise Value
678.62M
1-Year Change
46.35%
Ranking
Category
Stock Price
$3.20
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $477.06M, an increase of 61.29%. That is a compound annual growth rate of 15.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2025 | 477.06M | -5.60% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.26B |
| UnitedHealth Group | 479.18B |
| Novo Nordisk | 385.14B |
| Johnson & Johnson | 342.03B |
| AbbVie | 309.55B |
| Merck & Co. | 251.07B |
| AstraZeneca | 207.72B |
| Thermo Fisher Scientific | 207.43B |